These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19440086)

  • 21. The effects of galantamine on psychopathology in chronic stable schizophrenia.
    Conley RR; Boggs DL; Kelly DL; McMahon RP; Dickinson D; Feldman S; Ball MP; Buchanan RW
    Clin Neuropharmacol; 2009; 32(2):69-74. PubMed ID: 18978489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease.
    Grace J; Amick MM; Friedman JH
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):18-23. PubMed ID: 18931006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lithium treatment effects on the neuropsychological functioning of patients with bipolar I disorder.
    López-Jaramillo C; Lopera-Vásquez J; Ospina-Duque J; García J; Gallo A; Cortez V; Palacio C; Torrent C; Martínez-Arán A; Vieta E
    J Clin Psychiatry; 2010 Aug; 71(8):1055-60. PubMed ID: 20361895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression.
    Holtzheimer PE; Meeks TW; Kelley ME; Mufti M; Young R; McWhorter K; Vito N; Chismar R; Quinn S; Dey S; Byrd EH; McDonald WM
    Int J Geriatr Psychiatry; 2008 Jun; 23(6):625-31. PubMed ID: 18058832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial.
    Scarpini E; Bruno G; Zappalà G; Adami M; Richarz U; Gaudig M; Jacobs A; Schäuble B
    J Alzheimers Dis; 2011; 26(2):211-20. PubMed ID: 21606568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galantamine treatment of vascular dementia: a randomized trial.
    Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
    Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low compliance to pharmacological treatment is linked to cognitive impairment in euthymic phase of bipolar disorder.
    Fuentes I; Rizo-Méndez A; Jarne-Esparcia A
    J Affect Disord; 2016 May; 195():215-20. PubMed ID: 26897294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.
    Brown ES; Gorman AR; Hynan LS
    J Clin Psychopharmacol; 2007 Oct; 27(5):498-502. PubMed ID: 17873684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PET.
    Ellis JR; Nathan PJ; Villemagne VL; Mulligan RS; Saunder T; Young K; Smith CL; Welch J; Woodward M; Wesnes KA; Savage G; Rowe CC
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):79-91. PubMed ID: 18949462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of N-acetyl cysteine on cognitive function in bipolar disorder.
    Dean OM; Bush AI; Copolov DL; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):514-7. PubMed ID: 23066769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A five-year follow-up study of neurocognitive functioning in bipolar disorder.
    Santos JL; Aparicio A; Bagney A; Sánchez-Morla EM; Rodríguez-Jiménez R; Mateo J; Jiménez-Arriero MÁ
    Bipolar Disord; 2014 Nov; 16(7):722-31. PubMed ID: 24909395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Galantamine improves cognition in schizophrenic patients stabilized on risperidone.
    Schubert MH; Young KA; Hicks PB
    Biol Psychiatry; 2006 Sep; 60(6):530-3. PubMed ID: 16806095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia.
    Choueiry J; Blais CM; Shah D; Smith D; Fisher D; Labelle A; Knott V
    Int J Psychophysiol; 2019 Nov; 145():70-82. PubMed ID: 30790597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 12-month longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder.
    Torres IJ; Kozicky J; Popuri S; Bond DJ; Honer WG; Lam RW; Yatham LN
    Bipolar Disord; 2014 Mar; 16(2):159-71. PubMed ID: 24636366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.
    Burns A; Bernabei R; Bullock R; Cruz Jentoft AJ; Frölich L; Hock C; Raivio M; Triau E; Vandewoude M; Wimo A; Came E; Van Baelen B; Hammond GL; van Oene JC; Schwalen S
    Lancet Neurol; 2009 Jan; 8(1):39-47. PubMed ID: 19042161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of erythropoietin on cognition in affective disorders - Associations with baseline deficits and change in subjective cognitive complaints.
    Ott CV; Vinberg M; Kessing LV; Miskowiak KW
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1264-73. PubMed ID: 27349944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval.
    Mur M; Portella MJ; Martínez-Arán A; Pifarré J; Vieta E
    Acta Psychiatr Scand; 2008 Nov; 118(5):373-81. PubMed ID: 18759809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients.
    Whyte EM; Lenze EJ; Butters M; Skidmore E; Koenig K; Dew MA; Penrod L; Mulsant BH; Pollock BG; Cabacungan L; Reynolds CF; Munin MC
    Cerebrovasc Dis; 2008; 26(3):317-21. PubMed ID: 18667813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.